跳至主要内容
临床试验/JPRN-UMIN000004387
JPRN-UMIN000004387已完成未知

Effect of Garenoxacin to fever and pro-inflamatory cytokine with bronchoscopy - Effect of Garenoxacin to fever and pro-inflamatory cytokine with bronchoscopy

Keio University Hospital0 个研究点目标入组 60 人开始时间: 2010年10月14日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) patient who has history of hypersensitivity reaction or adverse event to quinolones (2) patients who can't be performed bronchoscopy because of respirotry disorder (3) patient who has disability of oral administration (4) patient who has history of convulsion or epilepsy or who has regular administration of anti- epileptic medicine (5) patients who has autoimmune disease or immuno-disorders (6) patients who has administration of systemic corticosteroid (7) patients who are administerd antibiotics within 2 weeks (8) pregnanct or possibility of pregnant or breast feeding (9) patients not suitable to administration of garenoxacin considered by attending physician (10) patients who has possibility of negative impact to diagnosis by administration of garenoxacin

研究者

相似试验